Catalyst Wire Dossier Catalyst Wire Dossier

DW340

· Daewon Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DW340, covering 2016-10-12 to 2018-02-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain [Phase 2]

See pricing